Skip to main content
AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc. — Investor Relations & Filings

Ticker · ANTX ISIN · US0373261058 US Manufacturing
Open in API
Filings indexed 339 across all filing types
Latest filing 2023-03-29 Annual Report
Country US United States of America
Listing US ANTX

About AN2 Therapeutics, Inc.

https://www.an2therapeutics.com/

AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing treatments for rare, chronic, and serious infectious diseases with high unmet medical needs. The company utilizes its proprietary boron chemistry platform to create novel small molecule therapeutics. Its development pipeline includes boron-based compounds, such as its lead candidate epetraborole, which are being investigated as potential first-in-class or best-in-class therapies. The company's mission is to deliver high-impact drugs to improve global health outcomes, with potential applications extending to oncology.

Recent filings

Filing Released Lang Actions
10-K
Annual Report FY 2022
2023-03-29 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events or updates. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release with financial results for the quarter and year ended December 31, 2022. However, the document itself is not the full financial report but a current report announcing the results and attaching the press release. The length is 3501 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report announcing financial results but not the full earnings release or annual report itself.
2023-03-29 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-24 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-18 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-18 English
FORM 4 SUBMISSION
Director's Dealing
2023-02-18 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.